hims - Search News

Hims & Hers to offer at-home blood draws and lab testing

Hosted on MSN · 22h

Hims & Hers to offer at-home blood draws, lean into 'peptide innovations' with new acquisitions

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Investopedia on MSN · 2d

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition

Key Takeaways Shares of Hims & Hers Health touched a fresh record high in Wednesday trading after the company announced its latest acquisition.The company said it acquired Trybe Labs, which will help Hims launch an at-home blood drawing and lab testing service.

GlobalData on MSN · 1d

Hims & Hers to introduce at-home lab testing with Trybe Labs acquisition

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of US-based Trybe Labs. This strategic move is set to enhance the company's ability to offer whole body testing and personalised healthcare solutions directly to customers.

HIMS, Hers Health Stock

Business Insider · 21h

Why Is HIMS Stock Dropping Today?

The U.S. FDA has officially declared that Novo Nordisk’s (NVO) popular diabetes and weight loss therapies, Ozempic and Wegovy, are no longer in

Money Morning · 22h

Why Is HIMS Stock Down So Much? Should You Buy?

HIMS stock plunged by 18% after the FDA news that resolved a shortage of weight-loss drugs like Ozempic and Wegovy, which previously allowed Hims & Hers to sell compounded alternatives. Compounded versions were permitted during the shortage but are now restricted unless they meet specific exceptions.

The Motley Fool on MSN · 18h

Why Hims & Hers Health Stock Is Plummeting Today

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as much as 26.1% earlier in the day. The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.3%.

17h

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.

1d

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

18hon MSN

Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

1d

Hims Expands Drug Manufacturing With California Peptide Plant Acquisition

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

14hon MSN

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Money Morning1d

Ozempic Maker Is Ready to Fight Back Against Hims & Hers

Shares of Hims & Hers Health (HIMS) are getting crushed today after the Food & Drug Administration determined there is no ...

1d

Hims & Hers plunges as the FDA says Novo’s weight loss drugs are not in shortage

Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisk's (NVO) weight loss therapies are no longer in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results